The development of a separation fluoriommunoassay for urinary
normetanephrine is described. Antiserum specific to normetanephrine was coupled, using cyanogen bromide, to magnetizable cellulose; and fluorescein labelled normetanephrine was synthesized from fluoresceinthiocarbarnylethylene diamine and a previously described normetanephrine derivative. Using these reagents it was possible to construct a reproducible standard curve, covering a wide range of concentrations, and to accurately measure the concentration of this metabolite in acid-hydrolysed urine samples. Cross-reactivities of structurally similar compounds were low and the fluoroimmunoassay showed good correlation with an established gas-chromatographic assay. The procedure is rapid; it is possible to accurately determine the normetanephrine concentration of urine samples approximately 2 h after hydrolysis, resulting in an overall assay time of approximately 4 h. This is the first report of a non-isotopic imrnunoassay for normetanephrine.
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Phaeochromocytomas and neuroblastomas are life-threatening tumours, generally associated with raised urinary concentrations of the catecholamines and their Phaeochromocytomas are usually located in the adrenal medulla, and generally secrete adrenaline and noradrenaline, the latter causing dangerous hypertension and a wide spectrum of other physiological effect^.^ Neuroblastornas are malignant tumours of early childhood that secrete mainly noradrenaline and dopamine and in which the survival rate is dependent upon the stage of the disease at d i a g n o s i~.~-~ Early diagnosis of phaeochromocytomas and neuroblastomas significantly improves prognosis and is often made by measurement of urinary catecholamine metabolites, with the demonstration of consistently elevated concentrations indicating the presence of a tumour. Assays for catecholamine metabolites are available, including spectrophotometric assays based on the work of Pisano6m7 and chromatographic techniques such as Correspondence: D r G. Gallacher at Queen Mary and Westfield College. gas chromatography (GC) and high-performance liquid chromatogroaphy (HPLC).8 However, these assays are not suited to screening large numbers of samples. Imunoassays are ideal for large sample numbers, but very few catecholamine immunoassays have been published because of difficulties associated with catecholamines and their metabolites, notably their small size and chemical instability.9
We recently reportedlo a novel strategy for the production of specific antisera for normetanephrine (I) via synthesis of the protected derivative (11) . We herein report the preparation of a normetanephrine-fluorescein conjugate (IV), and the development of a separation fluoroimmunoassay for urinary normetanephrine using the above antisera and fluorescein conjugate. This is the first description of a non-isotopic immunoassay for normetanephrine in urine.
MATERIALS AND METHODS
Chemicals were from Aldrich Chemical Co. (Gillingham, UK) and Sigma Chemical Co.
(Poole, UK); Triton X-100 from BDH Chemicals (Poole, UK); magnetizable cellulose particles from Scipac Ltd (Sittingbourne, UK); thin-layer chromatography plates (0.1 rnm silica) from Merck and Co. (Darmstadt, Germany) and 3-5 mL plastic tubes (55 x 12 mm; type 55.484) from Sarstedt (Leicester, UK).
All urine samples were collected over a 24 h period and acidified and had previously been sent to Queen Charlotte's Maternity Hospital, London, UK, for GC analysis. Fluorescence readings were performed on a Perkin-Elmer LS-5 fluorimeter (with excitation and emission wavelengths set at 489nm and 517nm, respectively), linked to a 3600 luminescence data station (Perkin-Elmer Instruments, Beaconsfield, UK). Assay buffer was 50 mmolar phosphate, pH 7.5, containing 0.1% sodium azide and 0.1% Triton X-100.
Solid phase antiserum
Antisera were obtained by immunizing three sheep with a conjugate prepared from butoxycarbonyl protected normetanephrine derivative (11) and keyhole-limpet haemocyanin as previously described (titres of approximately 2000 by polarization fluoroimmunoassay and 30 000 by Iz5I radioimmunoassay, respectively).I0 The most specific antiserum was covalently coupled to magnetizable cellulose particles at a ratio of 2 mL per g using cyanogen bromide. I ' These particles were suspended in assay buffer and stored at 4°C until required.
Normetanephrine-fluorescein conjugate (IV) (Fig. 1) N-t-Butoxycarbonyl-4-carboxymethylnormetane-
phrine'O ((11); 5 mg) in acetonitrile (1 mL) was treated with l-ethyl-3-(dimethylaminopropyl)carbodiimide hydrochloride (6 mg) and N-hydroxysuccinimide (3 mg) and stirred at room temperature for 1 h, when TLC (developing solvent dich1oromethane:methanol; 2: 1) showed complete formation of active ester (R, 0-80).
To this was added dropwise, over 15min. fluoresceinthiocarbamylethylene diamineI2 (6 mg) in water:triethylamine (9:l; 1 mL) and the reaction mixture was stirred for 1 h in the dark. Solvent was removed in vacuo and the orange product purified by TLC (eluting solvent dich1oromethane:methanol; 3: 1) to yield BOCprotected normetanephrine fluorescein conjugate (111) as one major band R, 0.43. This compound was deprotected by stirring with water:trifluoroacetic acid (7:3; 1 mL) for 1 h at room temperature. Solvent was removed in vacuo and the resulting normetanephrine fluorescein
Structures of: (I) normetanephrine; (II) tertbutovbonyl-protected nonnetanephrine derivative; (III) tert-butoxycarbonyl-protected normetanephrinefluorescein conjugate; (IV) normetanephrinefluorescein conjugate.
conjugate (IV) purified by TLC (developing solvent methanol; R, 0.50). The purified label was eluted with methanol (5 mL) and stored at -20°C in the dark.
Label dilution
Normetanephrine fluorescent label solution in methanol (50uL) from above was dissolved in 2 mL, 50 mmol/L sodium bicarbonate (ph 9-0) and the concentration determined at 492 nm assuming the molar extinction coefficient of fluorescein12 to be 8-78 x 10" L mol-'cm-', then diluted to 150 nmol/L in assay buffer.
Standard curves
Assays were performed in duplicate using normetanephrine standards prepared at 0.136, 0.273, 0.546,1.639,3.279and 10.929prnol/L (25,50, 100,300,600 and 2000 ug/L) in buffer (100 pL), to which were added, with vortex-mixing, normetanephrine fluorescein conjugate (1 50 nmol/L; 
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10-m antibody (100 pL; 1 -2 mg per tube) sufficient to give about 70% binding in the zero standard. After incubation with constant shaking for 1 h at room temperature, buffer (1 mL) was added to each tube and the particles sedimented on a magnetic rack for 5 min. The supernatants were decanted and the tubes inverted onto absorbent paper for 1 min to drain after which buffer (1 mL) was added to each tube and the particles sedimented, decanted and drained as above. Bound normetanephrine fluorescein conjugate was eluted from the solid phase using p H 9 -0 , 50 mmol/L bicarbonate buffermethanol 1 :4 (1 -4 mL) with constant shaking for 15 min. The magnetizable particles were sedirnented and the fluorescence of the supernatant read and compared against a tube containing only normetanephrine fluorescein conjugate (150 nmol/L; 100 uL) and elution reagent (1 -4 mL), to give percentage bound.
Specificity
Cross-reactivities of structurally similar compounds and other metabolites were assessed according to the method of Abraham.I3
Measurement of urine samples
Hydrochloric acid (2M; 200pL) was added to urine samples (2 mL) in loosely stoppered glass tubes which were immersed in a boiling water bath for 20 min. After cooling, sodium hydroxide solution (2M; 200 pL) was added, the pH of the urine adjusted to 7 -0 -8 -0 using 1M sodium hydroxide and the volume adjusted to 4 mL with assay buffer. Each sample (200 pL) was incubated in duplicate with normetanephrine fluorescein conjugate (150 nmol/L; 100 pL) and solid-phase antibody (100 pL) as above to give percentage bound and the value read directly from the standard curve.
RESULTS
Standard curve
A typical standard curve is shown in Fig. 2 . Good linearity was observed over the range 0.136 to 10-929pmol/L (25 to 2000pg/L) of normetanephrine.
Stability
Diluted reagents gave reproducible standard curves for at least 2 weeks when stored at 4°C. Standards stored at 4°C were stable for at least 1 month. Normetanephrine fluorescein conjugate stored in methanolic solution at -20°C and solid 
FIGURE 2. Normetanephrine standard curve and precision profile. A typical normetanephrine standard curve (a) with corresponding CVs (b) performed on buffered standards, to give a precision profile.
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phase antibody stored at 4°C in buffer containing 0.1% azide were stable for at least 1 year.
Specificity
Specificity of the assay was good, Octopamine which differs from normetanephrine only in lacking the 3-methoxyl group showed a crossreactivity of 5 -7%. All other compounds tested (adrenaline, noradrenaline, metanephrine, dopamine, DOPA, synephrine, 3methoxytyramine, 4-hydroxy-3-methoxyphenylglycol, 4-hydroxy3methoxymandelic acid, homovanillic acid, phenylephrine, norphenylephrine, methylaminomethylbenzyl alcohol and 2-aminol-phenylethanol) cross-reacted less than 1 To.
Precision (exclusive of the hydrolysis step)
Precision was assessed at 10 points on the standard curve between 0-136 and 10.929 pmol/L (25 and 2000 pg/L) on five mornings and afternoons in duplicate (n = lo), using buffered standards which had not been subjected to acid hydrolysis. Interassay CVs were less than 9% (Fig. 2) over this concentration range.
Precisian (inclusive of the hydrolysis step)
This was assessed using 'Biorad' pooled urine standards. The inter assay CV for a 'normal urine' 
FIGURE 3 . (a) Correlation of the concentrations of normetanephrine (in 29 urine samples from patients) determined by the new fluoroimmunomay and by an establkhed gas chromatography (GC) m a y . (b) Correlation of the amounts of normetanephrine excreted in 24 h for the above 29 urine samples; calculated from the volume of the urine sample and the concentration determined by thefluoroimmunoassay and by the GC assay.
was 5.3% ( n = 10). The intra assay CV for the 'normal urine' was 4.6% (n = 10). leads to an inconsistent antibody response and an inability to produce suitable labels. We have previously described the synthesis of a protected, stabilized normetanephrine derivative (11) and its use to produce specific normetanephrine antisera.I0 A normetanephrine fluorescein conjugate (IV) was prepared from the same derivative, and these reagents were used to develop a specific fluoroimmunoassay for normetanephrine. Specificity is excellent with the only appreciable cross-reactivity being w i t h octopamine which is excreted at concentrations of approximately 0-273-0-546pmol (50-100pg) per 24 h that do not appear to affect the assay.21 Precision, sensitivity and recovery are all good, and it is possible to accurately quantitate urine samples more quickly than by other methods presently available.
Minimum detectable concentration
Although our normetanephrine assay might be used alone to screen for phaeochromocytoma~,~~~ we believe that the best use of the assay will be in combination with immunoassays for complementary catecholamine metabolites to screen for phaecromocytoma and/or neuroblastoma. To this end we are developing similar immunoassays for other catecholamine metabolites. 10-24-25
